Table 1 Clinical features between community- and hospital-acquired MRSA in this study
Parameters |  | Groups | χ2 | P value | |||
|---|---|---|---|---|---|---|---|
CA-MRSA | % | HA-MRSA | % | ||||
Sex | Male | 9 | 56.2 | 14 | 58.3 | 0.017 | 0.896 |
Female | 7 | 43.8 | 10 | 41.7 | Â | Â | |
Age groups | ≤5 years | 12 | 75 | 0 | 0 | 33.52 | 0.000 |
5–18 years | 2 | 12.5 | 0 | 0 |  |  | |
18–50 years | 2 | 12.5 | 7 | 29.2 |  |  | |
>50 years | 0 | 0 | 17 | 70.8 |  |  | |
Clinical manifestation | Fever and pneumonia | 6 | 37.5 | 10 | 41.7 | 24.38 | 0.000 |
Respiratory symptoms (cough or expectoration) | 10 | 62.5 | 0 | 0 | Â | Â | |
Trauma | 0 | 0 | 3 | 12.5 | Â | Â | |
Tumor | 0 | 0 | 3 | 12.5 | Â | Â | |
Infections or others | 0 | 0 | 8 | 33.3 | Â | Â | |
Sample types | Sputum | 5 | 31.2 | 15 | 62.5 | 22.29 | 0.000 |
Nasopharyngeal aspiration | 10 | 62.5 | 0 | 0 | Â | Â | |
Blood | 1 | 6.2 | 1 | 4.2 | Â | Â | |
Secreta | 0 | 0 | 8 | 33.3 | Â | Â | |
Genotype profiles | ST6-t701 | 5 | 31.2 | 0 | 0 | 26.11 | 0.000 |
ST59-t437 | 5 | 31.2 | 10 | 41.7 | Â | Â | |
ST239-t030 | 0 | 0 | 14 | 58.3 | Â | Â | |
ST188-t189 | 2 | 12.6 | 0 | 0 | Â | Â | |
ST5-t14723 | 1 | 6.2 | 0 | 0 | Â | Â | |
ST965-t062 | 3 | 18.8 | 0 | 0 | Â | Â | |